Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Medtronic
Dow
Baxter
Colorcon

Last Updated: May 29, 2023

Bionpharma Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?

BIONPHARMA INC has forty-nine approved drugs.

There are five US patents protecting BIONPHARMA INC drugs.

There are ten patent family members on BIONPHARMA INC drugs in fourteen countries and seventy-four supplementary protection certificates in fourteen countries.

Summary for Bionpharma Inc
International Patents:10
US Patents:5
Tradenames:46
Ingredients:42
NDAs:49
Drug Master File Entries: 2
Patent Litigation for Bionpharma Inc: See patent lawsuits for Bionpharma Inc

Drugs and US Patents for Bionpharma Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc DICLOFENAC POTASSIUM diclofenac potassium CAPSULE;ORAL 204648-001 Feb 23, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma Inc PARICALCITOL paricalcitol CAPSULE;ORAL 202539-002 Mar 27, 2014 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma Inc CALCITRIOL calcitriol CAPSULE;ORAL 091174-001 May 24, 2013 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma Inc DEFERASIROX deferasirox TABLET, FOR SUSPENSION;ORAL 210920-002 Nov 20, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma Inc STAVZOR valproic acid CAPSULE, DELAYED RELEASE;ORAL 022152-003 Jul 29, 2008 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma Inc PARICALCITOL paricalcitol CAPSULE;ORAL 202539-001 Mar 27, 2014 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Bionpharma Inc IBUPROFEN ibuprofen CAPSULE;ORAL 078682-001 Mar 24, 2009 OTC No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Bionpharma Inc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0914118 C00914118/01 Switzerland ⤷  Try a Trial PRODUCT NAME: DEFERASIROX; REGISTRATION NUMBER/DATE: SWISSMEDIC 57466 03.11.2005
0719278 SPC/GB03/018 United Kingdom ⤷  Try a Trial PRODUCT NAME: DUTASTERIDE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SOLVATE.; REGISTERED: SE 17871 20020719; SE 17872 20020719; UK PL 19494/0005 20030117; UK PL 19494/0006 20030117
0764174 04C0021 France ⤷  Try a Trial PRODUCT NAME: COLESEVELAM HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/03/268/001 20040310
1411900 18/2011 Austria ⤷  Try a Trial PRODUCT NAME: NAPROXEN UND ESOMEPRAZOL SOWIE DEREN PHARMAZEUTISCH ANNEHMBARE SALZE; NAT. REGISTRATION NO/DATE: 1-29937 20110105; FIRST REGISTRATION: GB PL 17901/0263-0001 20101105
0245997 2000C/005 Belgium ⤷  Try a Trial PRODUCT NAME: DOFETILIDE; REGISTRATION NO/DATE: EU/1/99/121/001 19991129
1427415 SPC/GB11/042 United Kingdom ⤷  Try a Trial PRODUCT NAME: APIXABAN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/11/691/001 20110520; UK EU/1/11/691/002 20110520; UK EU/1/11/691/003 20110520; UK EU/1/11/691/004 20110520; UK EU/1/11/691/005 20110520
0716606 C00716606/01 Switzerland ⤷  Try a Trial PRODUCT NAME: SEVELAMER; REGISTRATION NUMBER/DATE: SWISSMEDIC 56297 10.02.2004
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Dow
Baxter
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.